vs
Side-by-side financial comparison of Lulu's Fashion Lounge Holdings, Inc. (LVLU) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Lulu's Fashion Lounge Holdings, Inc. is the larger business by last-quarter revenue ($66.1M vs $57.3M, roughly 1.2× RHYTHM PHARMACEUTICALS, INC.). Lulu's Fashion Lounge Holdings, Inc. runs the higher net margin — -48.2% vs -83.0%, a 34.8% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -11.8%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -14.7%).
Lulu's Fashion Lounge Holdings, Inc. is a direct-to-consumer women's fashion retailer offering affordable, trendy apparel, footwear, and accessories. It primarily serves Gen Z and millennial consumers across North America, operating mainly via its e-commerce platform, with limited pop-up physical locations to boost customer engagement.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
LVLU vs RYTM — Head-to-Head
Income Statement — Q4 FY2024 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $66.1M | $57.3M |
| Net Profit | $-31.9M | $-47.5M |
| Gross Margin | 37.9% | 91.6% |
| Operating Margin | -52.8% | -82.2% |
| Net Margin | -48.2% | -83.0% |
| Revenue YoY | -11.8% | 36.9% |
| Net Profit YoY | -340.9% | -9.6% |
| EPS (diluted) | $-13.46 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $57.3M | ||
| Q3 25 | — | $51.3M | ||
| Q2 25 | — | $48.5M | ||
| Q1 25 | — | $32.7M | ||
| Q4 24 | $66.1M | $41.8M | ||
| Q3 24 | $80.5M | $33.3M | ||
| Q2 24 | $92.0M | $29.1M | ||
| Q1 24 | $77.3M | $26.0M |
| Q4 25 | — | $-47.5M | ||
| Q3 25 | — | $-52.9M | ||
| Q2 25 | — | $-46.6M | ||
| Q1 25 | — | $-49.5M | ||
| Q4 24 | $-31.9M | $-43.3M | ||
| Q3 24 | $-6.9M | $-43.6M | ||
| Q2 24 | $-10.8M | $-32.3M | ||
| Q1 24 | $-5.7M | $-141.4M |
| Q4 25 | — | 91.6% | ||
| Q3 25 | — | 89.3% | ||
| Q2 25 | — | 88.6% | ||
| Q1 25 | — | 88.8% | ||
| Q4 24 | 37.9% | 90.9% | ||
| Q3 24 | 38.1% | 88.5% | ||
| Q2 24 | 45.5% | 89.9% | ||
| Q1 24 | 42.3% | 89.2% |
| Q4 25 | — | -82.2% | ||
| Q3 25 | — | -102.6% | ||
| Q2 25 | — | -93.4% | ||
| Q1 25 | — | -143.7% | ||
| Q4 24 | -52.8% | -98.6% | ||
| Q3 24 | -8.5% | -132.0% | ||
| Q2 24 | -4.9% | -139.2% | ||
| Q1 24 | -8.0% | -538.7% |
| Q4 25 | — | -83.0% | ||
| Q3 25 | — | -103.1% | ||
| Q2 25 | — | -96.1% | ||
| Q1 25 | — | -151.4% | ||
| Q4 24 | -48.2% | -103.6% | ||
| Q3 24 | -8.5% | -131.2% | ||
| Q2 24 | -11.7% | -110.9% | ||
| Q1 24 | -7.4% | -544.4% |
| Q4 25 | — | $-0.73 | ||
| Q3 25 | — | $-0.82 | ||
| Q2 25 | — | $-0.75 | ||
| Q1 25 | — | $-0.81 | ||
| Q4 24 | $-13.46 | $-0.71 | ||
| Q3 24 | $-2.47 | $-0.73 | ||
| Q2 24 | $-3.92 | $-0.55 | ||
| Q1 24 | $-0.15 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $13.4M | $139.1M |
| Total Assets | $108.2M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | — | $291.0M | ||
| Q1 25 | — | $314.5M | ||
| Q4 24 | $4.5M | $320.6M | ||
| Q3 24 | $6.3M | $298.4M | ||
| Q2 24 | $1.8M | $319.1M | ||
| Q1 24 | $5.5M | $201.2M |
| Q4 25 | — | $139.1M | ||
| Q3 25 | — | $148.8M | ||
| Q2 25 | — | $-11.9M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | $13.4M | $21.7M | ||
| Q3 24 | $43.8M | $11.2M | ||
| Q2 24 | $48.7M | $39.3M | ||
| Q1 24 | $57.7M | $61.6M |
| Q4 25 | — | $480.2M | ||
| Q3 25 | — | $506.9M | ||
| Q2 25 | — | $372.7M | ||
| Q1 25 | — | $386.7M | ||
| Q4 24 | $108.2M | $392.3M | ||
| Q3 24 | $153.5M | $363.6M | ||
| Q2 24 | $145.3M | $381.8M | ||
| Q1 24 | $160.6M | $258.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.5M | $-25.4M |
| Free Cash FlowOCF − Capex | $-2.6M | — |
| FCF MarginFCF / Revenue | -3.9% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-25.4M | ||
| Q3 25 | — | $-26.6M | ||
| Q2 25 | — | $-23.3M | ||
| Q1 25 | — | $-40.4M | ||
| Q4 24 | $-2.5M | $-18.8M | ||
| Q3 24 | $-5.5M | $-25.2M | ||
| Q2 24 | $3.7M | $-29.1M | ||
| Q1 24 | $6.9M | $-40.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-2.6M | — | ||
| Q3 24 | $-5.9M | — | ||
| Q2 24 | $3.4M | — | ||
| Q1 24 | $6.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | -7.3% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | 8.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.7% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LVLU
| Single Reportable Segment | $63.0M | 95% |
| Other | $2.4M | 4% |
| Stored Value Cards | $750.0K | 1% |
RYTM
Segment breakdown not available.
